| Ms Joyce A Kolias, CRNA | |
|
4320 Seminary Rd, Inova Alexandria Hospital, Alexandria, VA 22304-1535 | |
| (703) 504-3789 | |
| (703) 504-3556 |
| Full Name | Ms Joyce A Kolias |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 21 Years |
| Location | 4320 Seminary Rd, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275532749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | RN-0001188430 (Virginia) | Secondary |
| 207L00000X | Anesthesiology | CRNA-0024166032 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Company Llc | 4587559026 | 192 |
| Northstar Anesthesia Of Virginia, Llc | 6608268826 | 349 |
| Anesthesia Company Llc | 4587559026 | 192 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | American Anesthesiology Of Virginia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417994872 PECOS PAC ID: 6800790023 Enrollment ID: O20031120000429 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | North American Partners In Anesthesia (virginia), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922031442 PECOS PAC ID: 9931192739 Enrollment ID: O20040407000294 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | Surgical Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811930647 PECOS PAC ID: 5890739205 Enrollment ID: O20050616000610 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | Metromac Anesthesiology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437456951 PECOS PAC ID: 0648455097 Enrollment ID: O20110428000214 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | Capitol Anesthesia Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194106955 PECOS PAC ID: 3274848320 Enrollment ID: O20150818005376 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | Anesthesia Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871548156 PECOS PAC ID: 4587559026 Enrollment ID: O20180522001908 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Entity Name | Northstar Anesthesia Of Virginia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194488791 PECOS PAC ID: 6608268826 Enrollment ID: O20220120002585 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Joyce A Kolias, CRNA 3998 Fair Ridge Dr, Ste 300, Fairfax, VA 22033-2921 Ph: (703) 766-9737 | Ms Joyce A Kolias, CRNA 4320 Seminary Rd, Inova Alexandria Hospital, Alexandria, VA 22304-1535 Ph: (703) 504-3789 |
News Archive
Neovacs, a biotechnology company developing proprietary immunotherapies for autoimmune and chronic diseases, today announced the initiation of a Phase IIa clinical study of its TNFα Kinoid immunotherapy in rheumatoid arthritis patients who have ceased to respond to an anti-TNFα monoclonal antibody and who test positive for anti-drug antibodies (ADAs).
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,781,168 relating to methods of determining heart attack risk by detecting the Ile4399Met genetic polymorphism in the protease-like domain of LPA.
In a recent study, unemployed individuals were less likely to have health insurance and be up to date on getting recommended cancer screening tests.
Abortion rates are highest in countries that legally restrict access to terminations, but lowest in high-income countries where abortion and contraception are accessible, a new study has found.
› Verified 6 days ago
Dr. Talha Siddiqui, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 6164 Fuller Ct, Alexandria, VA 22310 Phone: 571-257-9580 | |
Reed S Underwood, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4320 Seminary Rd, Alexandria, VA 22304 Phone: 703-504-3789 Fax: 703-504-3556 | |
Dr. Julie A Miller, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2501 Parkers Ln, Alexandria, VA 22306 Phone: 703-295-9360 Fax: 703-295-9369 | |
Carl Anderson Smith, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 200 Duke St, Alexandria, VA 22314 Phone: 703-299-0125 | |
Dr. Rebecca L Freese, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2501 Parkers Ln, Alexandria, VA 22306 Phone: 703-664-7049 Fax: 703-295-9369 | |
Mrs. Cheryl V Lynch, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4320 Seminary Rd, Inova Alexandria Hospital, Alexandria, VA 22304 Phone: 703-504-3789 Fax: 703-504-3556 | |
Aristides John Michos, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4320 Seminary Rd, Alexandria, VA 22304 Phone: 703-504-3789 |